INSIGHTS ON CLINICAL TRIAL DESIGN
-
Improving Early Phase Oncology Trial Execution With A Site-First Approach
Trials that look good on paper often stall at the site. Learn how involving sites early in study design cuts delays and keeps early-phase cancer studies on track from startup to patients.
-
ASCO To EHA 2026: From Incremental Gains To Early Impact: What Biotechs Must Do Next
Oncology is moving to earlier treatment. Learn how ASCO and EHA 2026 results can help you design faster, earlier-line trials that stay relevant as standards of care change and access gaps persist.
-
ASGCT Symposium: Community-Based Cell & Gene Therapy Delivery
This symposium from ASGCT 2026 explores community-based delivery of cell & gene therapies as a means to improve access, equity, enrollment speed, data quality, and regulatory evidence.
-
Life Sciences Meetings Need More Than Logistics
Life sciences meetings often extend beyond investigators’ meetings. Strong planning helps teams support clinical, commercial, governance, and internal programs without adding pressure to the host team.
-
Merits Of A Multifaceted Approach To Clinical Trial Recruitment1/27/2025
The best way to address clinical trial recruitment challenges is with a multifaceted approach that goes beyond traditional channels and ways of thinking.
-
Where PRO Strategy Goes Wrong5/27/2026
PRO and COA strategy is now central to trial success. Organizations that capture meaningful patient experience data will gain stronger evidence and a regulatory advantage.
-
Precision Feasibility And RWD Can Boost Participant Recruitment11/17/2025
Discover how integrating independent, holistic data with precision feasibility strategies can transform site enablement and patient recruitment to unlock new levels of trial success.
-
Pioneering Clinical Research For Native American Communities In South Dakota1/31/2025
Lynn Bartholow is transforming clinical research for Native American populations. Explore her journey into clinical research and efforts to build trust and foster participation and community engagement.
-
Why Site Engagement Belongs At Investigators' Meetings8/4/2026
Investigators’ meetings are a great opportunity to give sites direct access to the teams supporting patient travel and reimbursement, clarify available services early, and surface practical needs before they become study barriers.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
-
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.
-
CVRM trials must address comorbidities and complex needs. See how real-world data and expertise improve design, speed recruitment, and advance cardiovascular, renal, and metabolic care.
-
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.